Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,458.00
-42.00 (-1.68%)
Sep 25, 2026, 3:15 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.02 trillion as of September 25, 2026. Its market cap has decreased by -2.11% in one year.
Market Cap
1.02T
Enterprise Value
1.07T
Revenue
147.38B
Ranking
n/a
PE Ratio
50.08
Stock Price
2,458.00
ChartMarket Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.02T, an increase of 79.40%. That is a compound annual growth rate of 18.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 1.02T | 12.73% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.55T |
| Zydus Lifesciences | 1.18T |
| Cipla | 1.13T |
| Laurus Labs | 1.09T |
| Aurobindo Pharma | 987.35B |
| Glenmark Pharmaceuticals | 685.86B |
| Alkem Laboratories | 636.80B |
| Ipca Laboratories | 506.67B |